Thyme Care

Thyme Care

Tech-enabled support for cancer patients

About Thyme Care

Simplify's Rating
Why Thyme Care is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

Data & Analytics

Healthcare

Company Size

201-500

Company Stage

Series C

Total Funding

$175M

Headquarters

Nashville, Tennessee

Founded

2020

Overview

Thyme Care provides support and guidance specifically for cancer patients, aiming to ensure they receive high-quality care throughout their treatment journey. The company integrates with existing clinical teams to offer continuous support, utilizing technology and oncology expertise to enhance patient care. Their services include personalized guidance for patients and act as an extension of healthcare providers' clinical teams, aligning incentives across the healthcare system. What sets Thyme Care apart from competitors is its focus on reducing the total cost of care through targeted interventions, which have been shown to lower inpatient spending and visits. The goal of Thyme Care is to deliver effective cancer care while minimizing treatment costs, benefiting both patients and healthcare providers.

Simplify Jobs

Simplify's Take

What believers are saying

  • Thyme Care projects 4x growth in 2025 due to increased demand.
  • The company secured $95M in funding to expand its value-based care platform.
  • Partnerships with major health plans enhance Thyme Care's national expansion.

What critics are saying

  • Increased competition in value-based oncology care threatens Thyme Care's market share.
  • Rapid expansion may lead to operational challenges and quality maintenance issues.
  • Reliance on technology exposes Thyme Care to data privacy and security risks.

What makes Thyme Care unique

  • Thyme Care offers a patient- and provider-integrated oncology solution.
  • The company focuses on personalized and holistic support for cancer patients.
  • Thyme Care reduces inpatient spend and visits, leading to significant savings.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$175M

Above

Industry Average

Funded Over

4 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Meet Average

Industry standards

$50M
$50M
Medium
$55M
Thyme Care
$62M
SeatGeek
$100M
Oura

Benefits

Health Insurance

Remote Work Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-5%

2 year growth

-2%
Yahoo Finance
Mar 12th, 2025
'Fatal To Fearless' Author And 2X Cancer Survivor Kathy Giusti Joins Thyme Care As Strategic Advisor, Patient Experience

Pharmaceutical insider who defied her three-year prognosis, established a $600M research fund, and tripled patient survival rates brings her patient advocacy expertise to Thyme Care to eliminate the barriers she faced in America's fragmented healthcare system NASHVILLE, Tenn., March 12, 2025 /PRNewswire/ -- Thyme Care, the leading value-based cancer care enabler, today announced that two-time cancer survivor and healthcare disruptor Kathy Giusti will join Thyme Care as a strategic Advisor for Patient Experience. The pharmaceutical executive-turned-patient advocate will collaborate with Thyme Care's team to further enhance its patient-centered care model with her unique insights—especially as Thyme Care expands into commercial and employer audiences, where people are balancing careers, families, and the many competing challenges of a cancer diagnosis. Thyme Care Logo (PRNewsfoto/Thyme Care) "Everyone with a new cancer diagnosis suddenly finds themselves needing to figure out how to navigate a ridiculously complicated health care system all while managing the physical and emotional effects of having cancer," said Bobby Green, MD, president, co-founder, and chief medical officer. "Kathy brings an extraordinary perspective to Thyme Care and will give us a level up in continuing to enhance our patient-centered model to meet the multifaceted needs of our members. While a cancer diagnosis has historically impacted older adults, today, younger people and women are getting diagnosed and face different challenges navigating the system than older generations. Kathy's expertise couldn't come at a more critical time." According to the American Cancer Society, 5,600 new people are diagnosed with cancer every day

Hospice News
Mar 4th, 2025
Humana, Thyme Care Partnership to Expand Access to Palliative Care

Thyme Care was established toward the end of 2020 following a $16 million funding round, led by Town Hall Ventures and Foresite Capital.

MobiHealthNews
Mar 3rd, 2025
Humana selects Thyme Care for oncology services

That same year, Thyme Care launched Enhanced Supportive Care, a virtual palliative care support program aimed at assisting its members and caregivers with managing physical and psychological symptoms accompanying cancer diagnosis and treatment.

JHConline
Feb 26th, 2025
Humana expands value-based oncology care through new agreement with Thyme Care

Humana expands value-based oncology care through new agreement with Thyme Care.

PR Newswire
Dec 17th, 2024
Thyme Care Projects 4X Growth In 2025 As Demand For Value-Based Oncology Care Surges; New Partnerships Bring Comprehensive Cancer Care Support To Over 40,000 Patients Across The Nation

Oak Street Health, EmblemHealth, Vytalize Health, and several large national health plans recognize Thyme Care's patient-centric navigation and deep provider relationships as a leading value-based model that delivers on the promise of better care at lower costsThyme Care generates savings and improves the cancer experience, fueling its national expansion across Medicare Advantage, commercial health plans, employers, provider groups, and CMS's Enhancing Oncology ModelThyme Care Oncology Partners (TCOP) doubles the number of oncologists in its network since launching in March; more than 850 oncologists represented from every major managed service organization now part of the platformNASHVILLE, Tenn., Dec. 17, 2024 /PRNewswire/ -- Thyme Care today announced new strategic partnerships across the cancer care continuum, enabling the company to achieve 4x year-over-year growth in 2025. With this momentum, Thyme Care expects to bring comprehensive cancer care support services to over 40,000 people with cancer.The cancer care system is nearing a financial and logistical breaking point, strained by systemic inefficiencies and gaps in care that burden patients, providers, and payers alike. Patients and caregivers struggle to navigate a complex and siloed healthcare ecosystem, and often experience barriers to care once they leave the physician's office. Oncologists, regardless of whether they practice in the community or a hospital setting, are not incentivized in the current fee-for-service environment to provide value-based care. These challenges inflate costs for everyone in the care continuum, bringing the entire system closer to a breaking point

Recently Posted Jobs

Sign up to get curated job recommendations

Thyme Care is Hiring for 35 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Thyme Care's jobs every few hours, so check again soon! Browse all jobs →